Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,427 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05168462RecruitingPhase 4
Lower blood pressure goal in heart-attack shock patients
This study compares two blood pressure targets in people with cardiogenic shock after a heart attack. It looks at whether the lower target can improve outcomes and help evaluate treatment costs.
AmsterdamAges 18 years+ - NCT05166694Recruiting
Personalized testing to check drug interactions and gene effects
This study uses personalized information to help understand how your current medicines interact with each other and with your genes. It may help your care team choose safer, more effective medication plans for you.
Chicago, IllinoisAges 18 years+ - NCT05180773RecruitingPhase 4
Bromocriptine for new postpartum heart weakness
This trial studies whether bromocriptine improves health outcomes in people recently diagnosed with peripartum cardiomyopathy (a weakened heart during late pregnancy or soon after delivery). You may be asked about timing after childbirth, heart strength tests, and whether you plan to keep breastfeeding.
Birmingham, AlabamaAges 18 years+ - NCT05189314Recruiting
Study of life quality changes with benign thyroid nodules
This study looks at how benign (non-cancer) thyroid nodules affect people’s day-to-day life and health outcomes. It may help doctors better understand what changes matter most to patients.
New York, New YorkAges 18 years+ - NCT05147103Enrolling by invitation
Checking how long low-intensity ultrasound lasts
This study looks at how long a low-intensity focused ultrasound treatment effect lasts. It may help researchers plan safer, more effective use of this technology in future studies.
Roanoke, VirginiaAges 18–65 - NCT05182957RecruitingPhase 2
Study of anti-PD-1, lenalidomide, and azacitidine for PTCL
This trial tests a combination of three medicines (anti-PD-1, lenalidomide, and azacitidine) for adults with relapsed or refractory peripheral T-cell lymphoma (PTCL) that is measurable or growing. It aims to shrink lymphoma and improve control of the disease when standard treatments haven’t worked or have stopped working.
Suzhou, JiangsuAges 18 years+ - NCT05181748RecruitingPhase 2/Phase 3
Platelet-rich plasma into ovaries for low egg response
This trial tests whether injecting your own platelet-rich plasma (PRP) into the ovaries can improve egg production in people who don’t respond well to fertility stimulation. It may help some “poor responders” get more usable eggs for IVF.
Athens, AtticaAges 35–47 - NCT05140265Recruiting
Uses EEG and medical records to build a privacy-protected database
This study creates a large, de-identified database by combining EEG test recordings with basic clinical information from medical records. It helps researchers use brain-wave data for future research while protecting your identity.
Albuquerque, New MexicoAges 18 years+ - NCT05177809Recruiting
Study of RFC1 gene changes in patients and healthy controls
This study tracks people with a specific genetic cause of RFC1-related disease, and compares them with healthy people without nervous system or mental health conditions. It helps researchers learn how the condition develops over time and what changes to watch for.
Melbourne, VictoriaAges 18 years+ - NCT05155501Recruiting
Surgery planning approaches for localized prostate cancer
This study compares different approaches used during prostate cancer surgery for men whose cancer is only in the prostate. It may help doctors choose the safest and most effective surgical plan for your situation.
Duarte, CaliforniaAges 40–80 - NCT02038660Recruiting
Drug-coated balloon treatment registry for narrowed blood vessels
This study records outcomes for people who get a drug-coated balloon used to treat a narrowed blood vessel after a first balloon treatment. It may help doctors understand how well this approach works in everyday care and for different patient needs.
Bucheon-siAges 20 years+ - NCT05102240Recruiting
Uses your cervix cancer treatment records to personalize therapy
This study builds computer models using past cervix cancer treatment data, including chemotherapy and radiation, plus MRI/CT images. It aims to help doctors choose more individualized treatment, based on what similar patients experienced and what their scans showed.
Navi Mumbai, MaharashtraAges 18–90 - NCT05072483Recruiting
Study of CADASIL’s natural course using blood tests and MRI
This study follows people with CADASIL (a genetic brain blood-vessel condition) to learn how it progresses over time. It uses blood and possibly tissue samples and brain MRI scans to better understand changes in the brain.
Bethesda, MarylandAges 18–100 - NCT05089890Recruiting
Sorbact dressings for hard-to-heal wounds
This trial tests a type of dressing that helps clean and heal wounds that have not improved for at least six weeks. The dressings are designed to trap and remove bacteria, which may help your wound heal faster.
MölndalAges 18 years+ - NCT05133882RecruitingPhase 1/Phase 2
Testing a targeted pill with chemotherapy for newly diagnosed AML
This study tests clifutinib (a targeted medicine) combined with chemotherapy in people newly diagnosed with AML. It aims to see if this combination is safer and more effective, including in older adults and people who may not tolerate strong chemotherapy.
Hanzhou, ZhejiangAges 18 years+ - NCT05130437RecruitingPhase 1/Phase 2
Follow-up study for an mRNA vaccine given before
This is a follow-up study for people who already received the mRNA-3927 vaccine in an earlier trial. It looks at how safe the treatment is over the long term and whether it continues to have benefit.
Los Angeles, CaliforniaAges 1 year+ - NCT05087745RecruitingEarly Phase 1
TIL therapy for advanced solid tumors
This trial tests a treatment that uses your own immune cells, called TILs, to fight advanced solid tumors. The cells are taken from a biopsy of your tumor, multiplied in a lab, and then given back to you. It might help if you have tried other treatments without success, or if no standard treatment is available.
Hangzhou, ZhejiangAges 18–75 - NCT05131750Recruiting
Study how RIR affects outcomes after heart stent procedures
This trial looks at a factor called RIR and whether it changes health outcomes for people with coronary heart disease who get a PCI (a heart stent procedure) while in the hospital. It may help doctors understand who benefits and how to improve care after stenting.
Wuhan, HubeiAges 18–80 - NCT05110144RecruitingPhase 2
Testing two doses of two nerve pain medicines for chronic cough
This Phase 2 study tests whether two doses of duloxetine and amitriptyline can reduce symptoms in people with chronic cough that hasn’t responded to usual care. You may join to see if these medicines lessen cough severity over an 8-week blinded treatment period.
Rochester, MinnesotaAges 18–75 - NCT05109208Recruiting
Ultrasound check for erection recovery after prostate surgery
This study looks at whether ultrasound imaging can help understand and improve erectile function after prostate removal surgery that aims to protect the nerves. If you’re interested in keeping or improving erections, your ultrasound results may be used to guide follow-up care.
Rochester, MinnesotaAges 40 years+ - NCT05098210RecruitingPhase 1
Personalized vaccine made from your tumor’s new immune targets
This Phase 1 study tests a customized vaccine made from “neo-antigens,” which are new targets found in your tumor. It aims to help your immune system fight certain advanced cancers that have not responded well to prior treatment.
Seattle, WashingtonAges 18 years+ - NCT05116930RecruitingPhase 2
Medicine for headache after a labor spinal needle
This Phase 2 study tests neostigmine plus glycopyrrolate to treat a specific type of severe headache that happens after a dural puncture during labor. If you have a new headache starting within 72 hours of delivery and no other cause, this treatment may help relieve your pain.
Rochester, MinnesotaAges 18–54 - NCT05116176Enrolling by invitation
Study of experiences after getting an ICD for heart protection
This study follows people who are scheduled to get a new ICD (a device that helps protect the heart) and asks about their experiences and quality of life. It may help doctors understand what patients feel and how people do after ICD implantation.
Boston, MassachusettsAges 65 years+ - NCT05110833Enrolling by invitation
Study dosing effects during monitored neck or chest spine surgery
This trial studies whether different medication dosing during monitored neck or upper chest spine surgery leads to better outcomes. You might help doctors figure out the most effective dosing approach for this type of surgery.
Minneapolis, MinnesotaAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,427 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.